It's temporary haemotoxicity which quickly resolves itself.
43 months overall survival vs 15 months for pluvicto.
At this stage Cu67 looks like being fairly close to pluvicto.
TLX591 looks well ahead.
Patients from Ph2 at over 20 months post treatment now,
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$3.80 |
Change
-0.580(13.2%) |
Mkt cap ! $1.413B | |||
| Open | High | Low | Value | Volume |
| $4.35 | $4.35 | $3.80 | $36.05M | 9.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 35320 | $3.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.82 | 1221 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |